802 related articles for article (PubMed ID: 28741464)
1. Expression of Mastoparan B, a Venom Peptide, Via Escherichia coli C43 (DE3) Coupled with an Artificial Oil Body-Cyanogen Bromide Technology Platform.
Hsieh SK; Yu YJ; Tang NY; Lin JR; Jinn TR
Protein Pept Lett; 2017; 24(11):1021-1029. PubMed ID: 28741464
[TBL] [Abstract][Full Text] [Related]
2. High-yield recombinant expression of the chicken antimicrobial peptide fowlicidin-2 in Escherichia coli.
Feng X; Xu W; Qu P; Li X; Xing L; Liu D; Jiao J; Wang J; Li Z; Liu C
Biotechnol Prog; 2015; 31(2):369-74. PubMed ID: 25641948
[TBL] [Abstract][Full Text] [Related]
3. Gene design, fusion technology and TEV cleavage conditions influence the purification of oxidized disulphide-rich venom peptides in Escherichia coli.
Sequeira AF; Turchetto J; Saez NJ; Peysson F; Ramond L; Duhoo Y; Blémont M; Fernandes VO; Gama LT; Ferreira LM; Guerreiro CI; Gilles N; Darbon H; Fontes CM; Vincentelli R
Microb Cell Fact; 2017 Jan; 16(1):4. PubMed ID: 28093085
[TBL] [Abstract][Full Text] [Related]
4. Expression of antimicrobial peptide LH multimers in Escherichia coli C43(DE3).
Tian ZG; Dong TT; Yang YL; Teng D; Wang JH
Appl Microbiol Biotechnol; 2009 May; 83(1):143-9. PubMed ID: 19205689
[TBL] [Abstract][Full Text] [Related]
5. [Efficient fusion expression of G13 domain derived from granulysin in Escherichia coli].
Liu X; Zha X; Xiao Y; Yang J; Li N
Sheng Wu Gong Cheng Xue Bao; 2009 Feb; 25(2):235-41. PubMed ID: 19459329
[TBL] [Abstract][Full Text] [Related]
6. Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels.
Miroux B; Walker JE
J Mol Biol; 1996 Jul; 260(3):289-98. PubMed ID: 8757792
[TBL] [Abstract][Full Text] [Related]
7. [Cloning and expression of a gene encoding shortened LfcinB(1-15)-Melittin(5-12) hybrid peptide in Escherichia coli BL21(DE3)].
Bi C; Feng X; Shan A; Guo J
Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):975-81. PubMed ID: 19835136
[TBL] [Abstract][Full Text] [Related]
8. Bacterial production of latarcin 2a, a potent antimicrobial peptide from spider venom.
Shlyapnikov YM; Andreev YA; Kozlov SA; Vassilevski AA; Grishin EV
Protein Expr Purif; 2008 Jul; 60(1):89-95. PubMed ID: 18455432
[TBL] [Abstract][Full Text] [Related]
9. High-level production of membrane proteins in E. coli BL21(DE3) by omitting the inducer IPTG.
Zhang Z; Kuipers G; Niemiec Ł; Baumgarten T; Slotboom DJ; de Gier JW; Hjelm A
Microb Cell Fact; 2015 Sep; 14():142. PubMed ID: 26377812
[TBL] [Abstract][Full Text] [Related]
10. Expression in Escherichia coli of fusion protein comprising α-conotoxin TxIB and preservation of selectivity to nicotinic acetylcholine receptors in the purified product.
Yu J; Zhu X; Yang Y; Luo S; Zhangsun D
Chem Biol Drug Des; 2018 Feb; 91(2):349-358. PubMed ID: 28891599
[TBL] [Abstract][Full Text] [Related]
11. Production and purification of a novel antibiotic peptide, adenoregulin, from a recombinant Escherichia coli.
Zhou YX; Cao W; Luo QP; Ma YS; Wang JZ; Wei DZ
Biotechnol Lett; 2005 May; 27(10):725-30. PubMed ID: 16049742
[TBL] [Abstract][Full Text] [Related]
12. Expression and purification of exendin-4 dimer in Escherichia coli and its interaction with GLP-1 receptor in vitro.
Yi L; Yin X; Wei D; Ma Y
Protein Pept Lett; 2006; 13(8):823-7. PubMed ID: 17073729
[TBL] [Abstract][Full Text] [Related]
13. The toxicity of recombinant proteins in Escherichia coli: a comparison of overexpression in BL21(DE3), C41(DE3), and C43(DE3).
Dumon-Seignovert L; Cariot G; Vuillard L
Protein Expr Purif; 2004 Sep; 37(1):203-6. PubMed ID: 15294299
[TBL] [Abstract][Full Text] [Related]
14. Optimization of expression and purification of two biologically active chimeric fusion proteins that consist of human interleukin-13 and Pseudomonas exotoxin in Escherichia coli.
Joshi BH; Puri RK
Protein Expr Purif; 2005 Feb; 39(2):189-98. PubMed ID: 15642470
[TBL] [Abstract][Full Text] [Related]
15. Higher efficiency soluble prokaryotic expression, purification, and structural analysis of antimicrobial peptide G13.
Che Y; Lu Y; Zha X; Huang H; Yang P; Ma L; Xu X
Protein Expr Purif; 2016 Mar; 119():45-50. PubMed ID: 26581777
[TBL] [Abstract][Full Text] [Related]
16. Expression of the cationic antimicrobial peptide lactoferricin fused with the anionic peptide in Escherichia coli.
Kim HK; Chun DS; Kim JS; Yun CH; Lee JH; Hong SK; Kang DK
Appl Microbiol Biotechnol; 2006 Sep; 72(2):330-8. PubMed ID: 16421719
[TBL] [Abstract][Full Text] [Related]
17. Functional expression, purification, and antimicrobial activity of a novel antimicrobial peptide MLH in Escherichia coli.
Gong GL; Wei Y; Wang ZZ
Prep Biochem Biotechnol; 2018 Jan; 48(1):57-63. PubMed ID: 29099325
[TBL] [Abstract][Full Text] [Related]
18. High-level expression of fusion peptide Dybowskin-2CDYa and hEGF in E. coli and its dual function.
Jin L; Jiang C; Zhang X; Wang Z; Hou X; Wang Q
Pak J Pharm Sci; 2014 May; 27(3 Suppl):637-42. PubMed ID: 24816706
[TBL] [Abstract][Full Text] [Related]
19. Solubility of disulfide-bonded proteins in the cytoplasm of Escherichia coli and its "oxidizing" mutant.
Xiong S; Wang YF; Ren XR; Li B; Zhang MY; Luo Y; Zhang L; Xie QL; Su KY
World J Gastroenterol; 2005 Feb; 11(7):1077-82. PubMed ID: 15742420
[TBL] [Abstract][Full Text] [Related]
20. Recombinant fusion proteins for the industrial production of disulfide bridge containing peptides: purification, oxidation without concatamer formation, and selective cleavage.
Döbeli H; Andres H; Breyer N; Draeger N; Sizmann D; Zuber MT; Weinert B; Wipf B
Protein Expr Purif; 1998 Apr; 12(3):404-14. PubMed ID: 9535709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
